Hematologic Malignant Neoplasms After Drug Exposure in Rheumatoid Arthritis
Author(s) -
Sasha Bernatsky
Publication year - 2008
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2007.107
Subject(s) - medicine , rheumatoid arthritis , cyclophosphamide , population , azathioprine , concomitant , methotrexate , surgery , disease , chemotherapy , environmental health
Rheumatoid arthritis is a severe inflammatory polyarthritis that requires long-term treatment with disease-modifying antirheumatic drugs. There is increasing concern about the influence of rheumatoid arthritis therapy on the risk for hematologic malignant neoplasms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom